Assignee
ANTAGONIS BIOTHERAPEUTICS GMBH
AT·2 granted patents·1 pending application·0 citations·filing 2015–2020
Top patents by PatentIndex Score
3 records- 0155US10703790B2Glycosaminoglycan-antagonising fusion proteinsANTAGONIS BIOTHERAPEUTICS GMBH·Filed 2018·Granted Jul 7, 2020·0 cites·2 claims
- 0246US10047133B2Glycosaminoglycan-antagonising fusion proteins and methods of using sameANTAGONIS BIOTHERAPEUTICS GMBH·Filed 2015·Granted Aug 14, 2018·0 cites·10 claims
- 0344US2022281934A1T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinityANTAGONIS BIOTHERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANTAGONIS BIOTHERAPEUTICS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →